title: Investigational treatments. How strict should we be?
authors.affiliation: Kaiser Health Plan and Permanente Medical Group of Southern California, Pasadena, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Eddy
mesh_terms: D026683:Advisory Committees; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D035061:Control Groups; D003363:Cost Control; D003657:Decision Making; D003695:Delivery of Health Care; D019317:Evidence-Based Medicine / Q000592:standards*; D006801:Humans; D019458:Insurance Coverage; D017063:Outcome Assessment, Health Care; D011787:Quality of Health Care; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards; D012109:Research Support as Topic; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation; D035703:Therapies, Investigational; D014481:United States